Fund Holdings — Aquilo Capital Management, LLC

Total Portfolio Value:
$0
Total Bought:
$0
Total Sold:
$37.08M
Net Transaction:
-$37.08M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
No Securities000$0$0—$0
Adicet Bio Inc2,456,1940-2,456,194$1.85M$0—-$1.85M
Arrowhead Pharmaceuticals, Inc.(ARWR)550,1300-550,130$7.01M$0—-$7.01M
Arvinas, Inc.(ARVN)360,7660-360,766$2.53M$0—-$2.53M
Bicycle Therapeutics PlcADS171,6950-171,695$1.46M$0—-$1.46M
Blueprint Medicines Corp83,9260-83,926$7.43M$0—-$7.43M
Immatics N.V.SHS(IMTX)304,9020-304,902$1.38M$0—-$1.38M
Kymera Therapeutics, Inc.(KYMR)138,5210-138,521$3.79M$0—-$3.79M
Precision BioSciences, Inc.(DTIL)726,1490-726,149$3.46M$0—-$3.46M
Protagonist Therapeutics Inc81,6920-81,692$3.95M$0—-$3.95M
REGENXBIO Inc.(RGNX)271,3020-271,302$1.94M$0—-$1.94M
Repare Therapeutics Inc1,293,7150-1,293,715$1.28M$0—-$1.28M
Zymeworks Inc.(ZYME)84,4820-84,482$1.01M$0—-$1.01M
Page 1 of 1
Aquilo Capital Management, LLC — 13F Holdings — Q2 2025 | TickerTrail